Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STATIC: Atorvastatin for Neuroprotection in Spontaneous Intracerebral Hemorrhage
NCT04857632Phase 3Recruiting
- Sponsor
- Capital Medical University
- Start
- Aug 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in intracerebral hemorrhage (ICH), sponsored by Capital Medical University. Started Aug 2021; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT04857632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04857632.